Delivery Order SPE2DE21D7020-SPE2D626F1840
- Not listed
- Boston Scientific Corp has been awarded a delivery order valued at $12,695.76 by the Defense Health Agency's Medical Supply Chain, an organization within the Department of Defense responsible for procuring medical devices and supplies for military healthcare systems. The contract, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, represents a fixed-price agreement with economic price adjustment provisions. The work will be performed at Boston Scientific's headquarters...
- Boston Scientific Corp was awarded a fixed-price delivery order with economic price adjustment valued at $1,476.84 by the Defense Health Agency's Medical Supply Chain program on September 4, 2025, with an ultimate completion date of September 11, 2025. The contract carries no set-aside designation, indicating open competition in the federal marketplace. Performance will be conducted at the company's facility in Marlborough, Massachusetts, where Boston Scientific manufactures advanced medical...
- Boston Scientific Corp has been awarded a delivery order valued at $15,928.65 by the Defense Health Agency's Medical Supply Chain for the supply of medical devices and equipment. The contract, issued on September 2, 2025, with an ultimate completion date of September 9, 2025, is structured as a fixed-price delivery order with economic price adjustment provisions. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order represents a...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order with economic price adjustment valued at $4,860 by the Defense Health Agency's Medical Supply Chain division on September 2, 2025. The delivery order, with an ultimate completion date of September 9, 2025, represents a short-duration task order for specialized medical devices or equipment. As a major federal contractor, Boston Scientific supplies...
- Boston Scientific Corp has been awarded a delivery order valued at $3,705.29 by the Defense Health Agency's Medical Supply Chain on July 18, 2025, with an ultimate completion date of July 25, 2025. This fixed-price contract with economic price adjustment authority represents a task order under a larger indefinite delivery vehicle and carries no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at the company's...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $6,118.95 by the Defense Health Agency's Medical Supply Chain on September 16, 2025. This fixed-price contract with economic price adjustment provisions has an ultimate completion date of September 23, 2025 and carries no set-aside designation, indicating open competition in the federal marketplace. The work will be performed at Boston Scientific's...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $1,727.26 by the Defense Health Agency's Medical Supply Chain on October 15, 2025. The contract, designated as a fixed-price agreement with economic price adjustment provisions, calls for delivery of specialized medical supplies with an ultimate completion date of October 22, 2025. The award was made without set-aside restrictions, allowing Boston...
- Boston Scientific Corp, a global medical device manufacturer headquartered in Marlborough, Massachusetts, was awarded a delivery order by the Defense Health Agency's Medical Supply Chain on September 29, 2025. This fixed-price contract with economic price adjustment carries a ceiling value of $3,362.95 and is scheduled for completion by October 6, 2025. The contract represents a single delivery order under Boston Scientific's established relationship with the Defense Health Agency and does not...
- Boston Scientific Corp has been awarded a delivery order valued at $1,677.60 by the Defense Health Agency's Medical Supply Chain division under a fixed-price contract with economic price adjustment provisions. The contract, issued on May 21, 2025, with an ultimate completion date of May 29, 2025, represents a non-set-aside award to the Marlborough, Massachusetts-based medical device manufacturer. This delivery order falls under Boston Scientific's existing indefinite delivery vehicle...
- Boston Scientific Corp has been awarded a delivery order valued at $2,903.20 under a Defense Health Agency Medical Supply Chain contract. The order, issued on September 2, 2025, with an ultimate completion date of September 9, 2025, represents a fixed-price contract with economic price adjustment terms. The work will be performed in Marlborough, Massachusetts, Boston Scientific's headquarters location. This delivery order was not issued under any small business set-aside program, indicating...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D626F1840Delivery Order
Boston Scientific Corp was awarded a fixed-price delivery order with economic price adjustment valued at $15,904.95 by the Defense Health Agency's Medical Supply Chain on October 15, 2025. The delivery order, which is not set aside for any specific business type, requires ultimate completion by October 22, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. As a global medical technology company specializing in advanced medical devices, Boston Scientific serves as a prime contractor to multiple federal healthcare agencies, providing critical equipment such as implantable cardiovascular devices, stents, catheters, and diagnostic tools. This delivery order represents a continuation of Boston Scientific's longstanding relationship with the Defense Health Agency and demonstrates the company's role as a key supplier within the federal medical device supply chain. Boston Scientific maintains significant indefinite delivery vehicles with federal agencies, including a $750,000 blanket purchase agreement with the DHA for radiation treatment devices extending through March 30, 2030. The company's federal contracting portfolio reflects its comprehensive capabilities across cardiovascular, interventional, and diagnostic medical technologies serving the Department of Veterans Affairs, Defense Health Agency, and Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.9k | 10/15/25 |